Literature DB >> 11956960

Involvement of dopamine in the progression of AIDS Dementia Complex.

E Koutsilieri1, S Sopper, C Scheller, V ter Meulen, P Riederer.   

Abstract

HIV compromises immunological functions. Immune responses are regulated to a great extent by several molecules such as cytokines, neurotransmitters and hormones which interact with different immune effector cells and ultimately mediate the homeostatic responses to disease. Among these mediators, dopamine plays an important role. In this article we review AIDS Dementia Complex (ADC) and describe lines of evidence implying increased dopamine availability as a potent mediator of neurologic deficits in HIV infection and a factor exhibiting adverse effects on the progression of ADC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11956960     DOI: 10.1007/s007020200032

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  32 in total

1.  Preferential sensitivity of human dopaminergic neurons to gp120-induced oxidative damage.

Authors:  Shuxian Hu; Wen S Sheng; James R Lokensgard; Phillip K Peterson; R Bryan Rock
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

Review 2.  Safety considerations in drug treatment of depression in HIV-positive patients: an updated review.

Authors:  Crystal C Watkins; Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

3.  Dopaminergic marker proteins in the substantia nigra of human immunodeficiency virus type 1-infected brains.

Authors:  Janelle M Silvers; Michael Y Aksenov; Marina V Aksenova; Jacob Beckley; Petra Olton; Charles F Mactutus; Rosemarie M Booze
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

4.  The role of catecholamines in HIV neuropathogenesis.

Authors:  R Nolan; P J Gaskill
Journal:  Brain Res       Date:  2018-04-27       Impact factor: 3.252

5.  [3H]Dopamine Uptake through the Dopamine and Norepinephrine Transporters is Decreased in the Prefrontal Cortex of Transgenic Mice Expressing HIV-1 Transactivator of Transcription Protein.

Authors:  Matthew Strauss; Bernadette O'Donovan; Yizhi Ma; Ziyu Xiao; Steven Lin; Michael T Bardo; Pavel I Ortinski; Jay P McLaughlin; Jun Zhu
Journal:  J Pharmacol Exp Ther       Date:  2020-05-27       Impact factor: 4.030

Review 6.  Large animal models of neurological disorders for gene therapy.

Authors:  Christine Gagliardi; Bruce A Bunnell
Journal:  ILAR J       Date:  2009

Review 7.  Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.

Authors:  Peter J Gaskill; Tina M Calderon; Jacqueline S Coley; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-01       Impact factor: 4.147

8.  Intra-accumbal Tat1-72 alters acute and sensitized responses to cocaine.

Authors:  S B Harrod; C F Mactutus; S Fitting; U Hasselrot; R M Booze
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

9.  Attenuated neurotoxicity of the transactivation-defective HIV-1 Tat protein in hippocampal cell cultures.

Authors:  Michael Y Aksenov; Marina V Aksenova; Charles F Mactutus; Rosemarie M Booze
Journal:  Exp Neurol       Date:  2009-07-15       Impact factor: 5.330

10.  In vivo microdialysis in awake, freely moving rats demonstrates HIV-1 Tat-induced alterations in dopamine transmission.

Authors:  Mark J Ferris; Danielle Frederick-Duus; Jim Fadel; Charles F Mactutus; Rosemarie M Booze
Journal:  Synapse       Date:  2009-03       Impact factor: 2.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.